Management of locally advanced renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q36555667

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Management of locally advanced renal cell carcinoma.

@ast

Management of locally advanced renal cell carcinoma.

@en

type

Item

label

Management of locally advanced renal cell carcinoma.

@ast

Management of locally advanced renal cell carcinoma.

@en

prefLabel

Management of locally advanced renal cell carcinoma.

@ast

Management of locally advanced renal cell carcinoma.

@en

P1476

Management of locally advanced renal cell carcinoma.

@en

P2093

Alejandro Rodriguez

http://www.w3.org/2001/XMLSchema#string

Wade J Sexton

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

Hypoxia--a key regulatory factor in tumour growth

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults.

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

P304

199-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327480601300307

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16885916

http://www.w3.org/2001/XMLSchema#string